Hyperintensity of the Middle Cerebellar Peduncles on Fluid-Attenuated Inversion Recovery Imaging: Variation with Age and Implications for the Diagnosis of Multiple System Atrophy

References

1. ↵
   Seppi K, Schocke MF, Wenning GK, et al. How to diagnose MSA early: the role of magnetic resonance imaging. J Neural Transm 2005;112:1625–34

   CrossRefPubMed
2. ↵
   Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65–71

   Abstract/FREE Full Text
3. ↵
   Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;55:1239–40

   PubMedWeb of Science
4. ↵
   Savoiardo M. Differential diagnosis of Parkinson’s disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003;24:S35–S37

   CrossRefPubMed
5. ↵
   Lee EA, Cho HI, Kim SS, et al. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2004;10:363–68

   CrossRefPubMed
6. ↵
   Burk K, Buhring U, Schulz JB, et al. Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia. Arch Neurol 2005;62:981–85

   CrossRefPubMed
7. ↵
   Naka H, Ohshita T, Murata Y, et al. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 2002;44:204–09

   CrossRefPubMedWeb of Science
8. ↵
   Yagishita T, Kojima S, Hirayama K. MRI study of degenerative process in multiple system atrophy [in Japanese]. Rinsho Shinkeigaku 1995;35:126–31

   PubMed
9. ↵
   Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354:1771–75

   CrossRefPubMedWeb of Science
10. ↵
    Wermuth L, Joensen P, Bunger N, et al. High prevalence of Parkinson’s disease in the Faroe Islands. Neurology 1997;49:426–32

    Abstract/FREE Full Text
11. ↵
    Chio A, Magnani C, Schiffer D. Prevalence of Parkinson’s disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998;13:400–05

    CrossRefPubMedWeb of Science
12. ↵
    Trenkwalder C, Schwarz J, Gebhard J, et al. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly: prevalence of Parkinson’s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995;52:1017–22

    CrossRefPubMedWeb of Science
13. ↵
    Wenning GK, Tison F, Seppi K, et al, and the Multiple System Atrophy Study Group. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004;19:1391–402

    CrossRefPubMedWeb of Science
14. ↵
    Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937–44

    CrossRefPubMedWeb of Science
15. ↵
    Schott JM, Simon JE, Fox NC, et al. Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Mov Disord 2003;18:955–58

    CrossRefPubMedWeb of Science
16. ↵
    Okamoto K, Tokiguchi S, Furusawa K, et al. MR features of diseases involving bilateral middle cerebellar peduncles. AJNR Am J Neuroradiol 2003;24:1946–54

    Abstract/FREE Full Text
17. ↵
    Limberg N, Jeavons S, Robertson T, et al. Pyramidal tract imaging in multiple-system atrophy. Mov Disord 2005;20:1527–28

    CrossRefPubMed